Molecular Formula | C22H20Cl2N4O4 |
Molar Mass | 475.32 |
Density | 1.415±0.06 g/cm3(Predicted) |
Boling Point | 644.7±55.0 °C(Predicted) |
Solubility | 2.5mg/mL in DMSO,10mg/mL in DMF, slightly soluble in ethanol |
Appearance | powder |
Color | white to beige |
pKa | 4.69±0.10(Predicted) |
Storage Condition | 2-8°C |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
Use | ML-210 is a selective, covalent glutathione peroxidase 4 (GPX4) inhibitor with an EC50 of 30 nM. ML-210 binds GPX4 selenocysteine residues. ML210 has anticancer activity. |
In vitro study | ML-210 exhibits cell-killing activity across a panel of 821 cancer cell lines (WM88, LOX-IMVI, CJM, U257, CAKI2, A498, HT1080, MC38, PANC02). ML-210 is a prodrug that requires cellular activation to bind GPX4. ML-210 has IC 50 s of 71 nM, 272 nM and 107nM for BJeLR (HRAS V12 ), BJeH-LT (without HRAS V12 ) and DRD cell lines, respectively. |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.104 ml | 10.519 ml | 21.038 ml |
5 mM | 0.421 ml | 2.104 ml | 4.208 ml |
10 mM | 0.21 ml | 1.052 ml | 2.104 ml |
5 mM | 0.042 ml | 0.21 ml | 0.421 ml |
biological activity | ML-210 (CID 49766530) is a selective covalent inhibitor of glutathione peroxidase 4 (GPX4), its EC50 value is 0.04 μm, which can induce Iron death. ML-210 can selectively kill cells that induce the expression of mutant RAS, and has anti-cancer activity. |
Target | Value |
RAS () | |
GPX4 (Cell-free assay) | 0.04 μM(EC50) |